tiprankstipranks
NDT Pharmaceuticals, Inc. (NDTP)
OTHER OTC:NDTP
US Market

NDT Pharmaceuticals (NDTP) Income Statement

8 Followers

NDT Pharmaceuticals Income Statement

Last quarter (Q ), NDT Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, NDT Pharmaceuticals's net income was $-20.82K. See NDT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 07Dec 06Dec 05
Total Revenue
----
Cost of Revenue
--$ 14.23K-
Gross Profit
--$ -14.23K-
Operating Expense
$ 72.03K$ 61.43K$ 37.53K$ 5.77K
Operating Income
$ -72.03K$ -61.43K$ -51.76K$ -5.77K
Net Non Operating Interest Income Expense
----
Other Income Expense
$ -24.31K$ -1.00M--
Pretax Income
----
Tax Provision
----
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -1.05M$ -1.04M$ -51.76K$ -5.77K
Basic EPS
$ -0.48$ -0.03$ >-0.01$ >-0.01
Diluted EPS
$ -0.48$ -0.03$ >-0.01$ >-0.01
Basic Average Shares
$ 385.21M$ 42.03M$ 33.96M$ 13.47M
Diluted Average Shares
$ 385.21M$ 42.03M$ 33.96M$ 13.47M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 72.03K$ 61.43K$ 51.76K$ 5.77K
Interest Expense
----
Net Income From Continuing And Discontinued Operation
$ -1.05M$ -1.04M$ -51.76K$ -5.77K
Normalized Income
$ -1.03M$ -35.60K$ -51.76K$ -5.77K
EBIT
$ -72.03K$ -61.43K$ -51.76K$ -5.77K
EBITDA
$ -72.03K$ -61.43K$ -51.76K$ -5.77K
Currency in USD

NDT Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis